C. Thallinger, G. Prager, H. Ringl, C. Zielinski: [Abscopal effect in the treatment of malignant melanoma]. In: Der Hautarzt; Zeitschrift Für Dermatologie, Venerologie, und verwandte Gebiete. Band66, Nr.7, 1. Juli 2015, S.545–548, doi:10.1007/s00105-014-3567-8, PMID 25576145.
R. J. Bramhall, K. Mahady, A. H. S. Peach: Spontaneous regression of metastatic melanoma – clinical evidence of the abscopal effect. In: European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. Band40, Nr.1, 2014, S.34–41, doi:10.1016/j.ejso.2013.09.026, PMID 24139999.
Yazan Abuodeh, Puja Venkat, Sungjune Kim: Systematic review of case reports on the abscopal effect. In: Current Problems in Cancer. Band40, Nr.1, S.25–37, doi:10.1016/j.currproblcancer.2015.10.001.
M. Zahidunnabi Dewan, Ashley E. Galloway, Noriko Kawashima, J. Keith Dewyngaert, James S. Babb: Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. In: Clinical Cancer Research. Band15, Nr.17, 1. September 2009, S.5379–5388, doi:10.1158/1078-0432.CCR-09-0265, PMID 19706802, PMC 2746048 (freier Volltext).
C. Thallinger, G. Prager, H. Ringl, C. Zielinski: [Abscopal effect in the treatment of malignant melanoma]. In: Der Hautarzt; Zeitschrift Für Dermatologie, Venerologie, und verwandte Gebiete. Band66, Nr.7, 1. Juli 2015, S.545–548, doi:10.1007/s00105-014-3567-8, PMID 25576145.
R. J. Bramhall, K. Mahady, A. H. S. Peach: Spontaneous regression of metastatic melanoma – clinical evidence of the abscopal effect. In: European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. Band40, Nr.1, 2014, S.34–41, doi:10.1016/j.ejso.2013.09.026, PMID 24139999.
M. Zahidunnabi Dewan, Ashley E. Galloway, Noriko Kawashima, J. Keith Dewyngaert, James S. Babb: Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. In: Clinical Cancer Research. Band15, Nr.17, 1. September 2009, S.5379–5388, doi:10.1158/1078-0432.CCR-09-0265, PMID 19706802, PMC 2746048 (freier Volltext).